Atlas Trials

Predictors of Response to Combined Pegylated Interferon and Ribavirin in Chronic Hepatitis C Infected Egyptian Patients

Clinical trial NCT01758939 · UNKNOWN

Trial details

NCT number
NCT01758939
Sponsor
Cairo University
Status
UNKNOWN
Study type
OBSERVATIONAL
Hepatitis C, Chronic
Start date
2011-01-01
Primary completion
2016-01-01
Enrollment
100000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.